Jennerex and Lee’s Pharm announces that its phase 2 study of Pexa-Vec in second-line advanced liver cancer did not meet its primary endpoint 2013.09.04

 
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD